Pfizer: Aamir Malik, chief business innovation officer and executive VP
The pharmaceutical firm has named Aamir Malik to its leadership team as executive vice president and chief business innovation officer. He succeeds John Young, who recently announced his retirement after 34 years with the firm.
Albert Bourla, CEO and chairman of Pfizer, said, “Aamir brings with him 25 years of experience developing innovative growth strategies, guiding mergers and acquisitions, and implementing high-impact programs to improve patients' lives and transform performance for life science companies. He is the ideal leader to drive these efforts.”
